Interações medicamentosas
Risankizumab + Upadacitinib
Gravidade: Grave
Risankizumab and Upadacitinib: major interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Risankizumab blocks IL-23 and upadacitinib inhibits JAK signaling. They are sometimes considered together in inflammatory bowel disease, but combined immunosuppression may increase infection risk and data on safety are limited.
O que esta interação significa em palavras simples
Risankizumab and Upadacitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Risankizumab belongs to Miscellaneous; Upadacitinib belongs to Musculoskeletal.
Por que acontece
Additive immunosuppression through IL-23 blockade and JAK inhibition.
O que fazer
Avoid routine combination; if used, screen for tuberculosis and hepatitis beforehand and monitor for infections.
O que perguntar ao farmacêutico
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Risankizumab e Upadacitinib, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 7 dias na web. Sem cartão.
Outras interações de Upadacitinib
- Abrocitinib + Upadacitinib Contraindicada
- Adenovirus types 4 and 7 live + Upadacitinib Contraindicada
- Baricitinib + Upadacitinib Contraindicada
- Bcg vaccine live + Upadacitinib Contraindicada
- Cyclosporine + Upadacitinib Contraindicada
- Dengue vaccine + Upadacitinib Contraindicada
Outras interações de Risankizumab
Perguntas frequentes
Can I take Risankizumab with Upadacitinib?
MediHelp rates the interaction as major. Risankizumab and Upadacitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Risankizumab blocks IL-23 and upadacitinib inhibits JAK signaling. They are sometimes considered together in inflammatory bowel disease, but combined immunosuppression may increase infection risk and data on safety are limited.
How serious is the interaction between Risankizumab and Upadacitinib?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid routine combination; if used, screen for tuberculosis and hepatitis beforehand and monitor for infections.
What other medicines interact with Upadacitinib?
MediHelp also lists interactions of Upadacitinib with, for example, Abrocitinib, Adenovirus types 4 and 7 live, Baricitinib. The full list is on the Upadacitinib page.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
